Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-035730

CEO and CFO bought 2,000 shares at $8.63 ($17,260)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2023-10-04 Purchase +2,000 $8.63 $17,260 5,298,177 D
Open-market purchases · 2,000 sh · avg $8.63 · $17,260
Loading xslF345X05/ownership.xml…